Article
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Oct 2025
Vromen Eleonora M, Lageman Senne B, Gobom Johan, van der Kant Rik, Dobricic Valerija, Bertram Lars, Streffer Johannes, Lovestone Simon, Vos Stephanie J B, Tainta Mikel, Freund-Levi Yvonne, Frölich Lutz, Popp Julius, Peyratout Gwendoline, Tsolaki Magda, Verhey Frans, Vandenberghe Rik, Schaeverbeke Jolien, Blennow Kaj, van der Lee Sven J, Scheltens Philip, Pijnenburg Yolande A L, van der Flier Wiesje M, Teunissen Charlotte E, Zetterberg Henrik, Visser Pieter Jelle, Tijms Betty
Abstract excerpt
BACKGROUND: The apolipoprotein E (APOE) gene includes the strongest protective (ε2) and risk (ε4) variants for sporadic Alzheimer's disease (AD), but underlying mechanisms remain unclear. We studied APOE genotype effects on the cerebrospinal fluid (CSF) proteome. METHODS: Using untargeted tandem mass tag mass spectrometry, we analyzed CSF from 227 cognitively normal (CN) controls (A-T-), 165 CN A+, and 177...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
